REFERENCES
- Merluzzi VJ, Hargrave KD, Labadia M, et al. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science. 1990;250:1411–1413.
- Haylir D, Cheeseman SH, McLaughlin M, et al. High-dose nevirapine: Safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis. 1995;171:537–545.
- Montaner JSG, Reiss P, Cooper D, et al. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients. The INCAS trial. JAMA. 1998;279:930–937.
- Katlama C, Murphy R, Johnson V, et al. The Atlantic study: A randomised open-label study comparing two protease inhibitors (PI)-sparing antiretroviral strategies versus a standard P1-containing regimen. Sixth Conference on Retroviruses and Opportunistic Infections; January 1999; San Francisco. Abstract 18.
- De Clerq E. The role of non-nucleoside reverse tran-scriptase inhibitors (NNRTIs) in the therapy of HIV-1 infec-tion. Antiviral Res. 1998;38:153–179.
- Carpenter CCJ, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults. Updated recommendations of the Inter-national AIDS Society USA-Panel. JAMA. 2000;283:381–390.
- Bardsley-Elliot A, Plosker GL. Nelfinavir. An update on its use in HIV infection. Drugs. 2000;59:581–620.
- Shafer RW, Stevenson D, Chan B. Human immunodefi-ciency virus reverse transcriptase and protease sequence database. Nucleic Acids Res. 1999;27:348–352.
- Korber B, Hahn B, Foley B, et al., eds. Human Retroviruses and AIDS 1997: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos, NM: Theoretical Biology and Biophysics Group, Los Alamos National Labo-ratory.
- Sullivan AK, Nelson MR, Shaw A, et al. Efficacy of a nelfinavir- and nevirapine-containing salvage regimen. HIV Clin Trials. 2000;1:7–12.
- Gilmour JG, Gregson DB, Done BL. Nelfinavir-nevirapine rescue therapy for patients failing protease inhibitor based therapy. XlIth International Conference on AIDS; June 1998; Geneva. Abstract 22375.
- Farthing C, Mess T, Reid C, et al. Ritonavir, saquinavir and nevirapine as a salvage regimen for indinavir or ritonavir resistance. XlIth International Conference on AIDS; June 1998; Geneva. Abstract 22356.
- Lawrence J, Schapiro J, Winters M, et al. Salvage therapy with indinavir plus nevirapine in patients previously treated with two other protease inhibitors and multiple reverse transcriptase inhibitors. Fifth Conference on Retroviruses and Opportunistic Infections; February 1998; Chicago. Ab-stract 422.
- Casado JL, Hertogs K, Ruiz L, et al. Non-nucleoside re-verse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regi-men. AIDS. 2000;14:F1–F7.
- Hirsch MS, Brun-Vézinet F, D'Aquila RT, et al. Antiretroviral drug resistance testing in adult HIV-1 infection. Recom-mendations of an International AIDS Society-USA Panel. JAMA. 2000;283:2417–2426.
- Pérez-Molina JA, Alonso R. The role of genotypic resis-tance testing in selecting therapy for HIV. JAMA. 2000;284:1649–1650.